Molecular Diagnosis of Urinary Tract Pathogens
Lori Millner, PhD, NRCC
Our Educational Symposium is designed for Administrators, Director of Nursing, and nursing staff that provide care to elderly and developmentally disabled persons. Our desire is to provide networking among leaders in the Post-Acute Care, Long Term Care, and Assisted Living industry while providing education on hot button issues. We hope that participants leave with the knowledge and tools to prepare them for the future.
These presentations provide education on tools to improve the quality of care. The following topic will be presented: molecular diagnostics and their role in therapy.
Learning Objectives Include
- Summarize current molecular methods to detect urinary tract pathogens.
- Describe what is published regarding correlation of traditional culture methods versus molecular methods.
- Describe use of molecular methods in polymicrobial infections.
* Registration and attendance is free.
* This program is approved for Continuing Education for a total of 1 participant hour by NAB/NCERS. Approval Code 20230125-1-A80178-DL.
* This educational offering has been reviewed by PCA Pharmacy and is approved for 1.2 contact hours. PCA Pharmacy is an approved Kentucky Board of Nursing provider until December 31, 2023. KBN# 7-0019-1221-010.
* If you register for this symposium and do not attend, you may receive a recording of the symposium. However, you will NOT receive any CEs for viewing the recording.
Lori Millner, PhD, NRCC
Dr. Lori Millner received her PhD in 2011 from the University of Louisville in Pharmacology and Toxicology. Her dissertation focused on the characterization of a phase II metabolic enzyme, N-acetyltranferase, for which she received the K. C. Huang Outstanding Graduate Student of the Year Award and the Dean’s Citation. Following completion of her doctorate, she completed a one year postdoctoral fellowship where she researched Circulating Tumor Cells (CTCs) and cell free nucleic acid (cfNA). In 2012, she entered a 3 year COMACC accredited fellowship in Clinical Chemistry and Toxicology at the University of Louisville Hospital Laboratory. While in the hospital fellowship, Dr. Millner was trained to be a Laboratory Director and responded to over 200 beeper calls and physician inquiries in the University of Louisville Hospital’s high complexity laboratory. During the fellowship, she also continued her research on CTCs and was the lead author on a funded SBIR grant.Dr. Millner has several peer reviewed and published manuscripts and has won numerous awards for her research including the Young Investigator Award and Best Abstract Award from the American Association of Clinical Chemists and the Young Scientist Award (Innovator in Science) from the Association of Clinical Scientists. Dr. Millner has served as a consultant for numerous clinical laboratories and has been the director of a high complexity, full service regional reference laboratory (including COVID-19 testing) for the last five years. She has performed several laboratory developed test validations and has experience with many different manufacturers in molecular diagnostic testing.